EGF mutant receptor vIII as a molecular target in cancer therapy.

in Endocrine-Related Cancer

If the inline PDF is not rendering correctly, you can download the PDF file here.


      Society for Endocrinology

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 590 478 15
PDF Downloads 308 248 15